AB Science reports its revenues for the year 2022 and provid

PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2022 AND THE KEY EVENTS OF THE PERIOD Financial information and other corporate information Consolidated operating

Related Keywords

France , United States , Spain , Greece , Canada , Paris , France General , French , Canadians , Alain Moussy , Drug Administration , Health Canada , Renewal Of The Programme , Euronext , French Medicine Agency , Paris Court , European Medicines Agency , European Medicine Agency , European Investment Bank , Committee For Medicinal Products Human Use , Enforcement Committee , Augmentation De Capital , Alpha Blue , New Drug Submission , New Drug , Marketing Authorization , Medicinal Products , Human Use , Primary Progressive Multiple Sclerosis , Secondary Progressive Multiple Sclerosis , Expanded Disability Status Scale , Daily Living , Mini Mental State Examination , Capital Increase , French Commercial Code , French Monetary , Financial Code , Combined General Shareholder Meeting , New Shares , European Investment , Blue Ocean , Euronext Paris , Alpha Blue Ocean , Science , Reports , Revenues , Ear , 022 , Rovides , Update , Activities ,